Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
MERGERS AND ACQUISITIONS
Gilead Sciences to Buy Cancer Drug Developer Forty Seven for $4.9 Billion
By M. Corey Goldman
Mar 2, 2020 10:24 AM EST
PRESS RELEASES
Forty Seven And Rocket Pharmaceuticals Announce Research Collaboration For Fanconi Anemia
By GlobeNewswire
Mar 11, 2020 8:00 AM EDT
PRESS RELEASES
Moore Kuehn Encourages FTSV, MINI, POPE, WAAS, And TLRA Investors To Contact Law Firm
By PR Newswire
Mar 4, 2020 10:13 AM EST
PRESS RELEASES
SHAREHOLDER ALERT: WeissLaw LLP Investigates Forty Seven, Inc.
By PR Newswire
Mar 3, 2020 5:36 PM EST
PRESS RELEASES
(FTSV) Alert: Johnson Fistel Investigates Proposed Sale Of Forty Seven, Inc.; Are Shareholders Getting A Fair Deal?
By PR Newswire
Mar 2, 2020 9:00 AM EST
MERGERS AND ACQUISITIONS
Gilead Sciences to Buy Cancer Drug Developer Forty Seven for $4.9 Billion
By M. Corey Goldman
Mar 2, 2020 10:24 AM EST
PRESS RELEASES
Gilead To Acquire Forty Seven For $4.9 Billion
By Business Wire
Mar 2, 2020 6:55 AM EST
INVESTING
Gilead Approaches Forty Seven With Takeover Offer
By Rob Lenihan
Feb 28, 2020 9:27 AM EST
PRESS RELEASES
Forty Seven To Present At Upcoming Investor Conferences In March
By GlobeNewswire
Feb 25, 2020 8:00 AM EST
PRESS RELEASES
Forty Seven To Present At Upcoming Investor Conferences In February
By GlobeNewswire
Feb 6, 2020 8:00 AM EST
